Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesThe role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection
The International Journal of Tuberculosis and Lung Disease, 08/12/09
Bliven EE et al. – Owing to the limited number of published papers, CVH was not established as a risk factor for INH hepatotoxicity during LTBI treatment. Controlled studies are needed to define the safety and tolerability of LTBI treatment in those with CVH and to provide an evidence base for recommendations for LTBI treatment in persons with CVH.
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Liver disease: Early signs you may be missing
APCToday, 10/21/09
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Severe sepsis in cirrhosis
Hepatology, 11/04/09
Sponsor
Article Search
Sponsor